Peer Review History
| Original SubmissionJuly 8, 2025 |
|---|
|
-->PONE-D-25-36668-->-->Household air pollution is associated with disease severity in Ugandan children hospitalized with hypoxemic pneumonia-->-->PLOS One Dear Dr. Hawkes, Thank you for submitting your manuscript to PLOS ONE. Though the paper has been reviewed by several reviewers, the responses of the comments are still missing. Please provide the responses to the comments and re-submit the revised paper according the comments made by all the reviewers and indicating how and where the comments have been addressed. Additionally, you are requested address some fresh comments made by me as mentioned below. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.-->--> -->-->Academic Editor comments:-->-->:-->-->1. The authors needs to provide the function from which the PM2.5 exposures were made from household characteristics along with its vital information about the model used.-->-->.2. Authors need to express the computational formula for the calculation of the sample size with input variable values. Only mentioning about the software is not appropriate.-->-->3, It needs to be clarified why non-parametric test was used instead of parametric test for measuring comparative statistics.-->-->4. It needs to be clarified how the odds ratios of different outcomes for risk factors were calculated along with their confidence intervals in the methodology section.-->-->5. I could not find the questionnaire for the SICK score calculation with reference. Please add it in supplementary.-->--> Please submit your revised manuscript by May 02 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
-->If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Srijan Lal Shrestha, Ph.D. Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2.Thank you for stating the following financial disclosure: [This study was supported by Grand Challenges Canada (Grant Number 1909-27795 [MH]) and The Women and Children’s Health Research Institute (Reference Number WCHSSLDRP 2371).]. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. We note that there is identifying data in the Supporting Information file < Ahmed HAP data for analysis.csv>. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws. Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared: -Name, initials, physical address -Ages more specific than whole numbers -Internet protocol (IP) address -Specific dates (birth dates, death dates, examination dates, etc.) -Contact information such as phone number or email address -Location data -ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order) Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long. Please remove or anonymize all personal information (ID, AGE,), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: The authors are requested to provide responses and revisions according to all the reviewers comments. Please kindly clarify how and where the comments have been addressed in the revised paper. Additional comments will be made only after going through the revised paper. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** -->2. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: This manuscript presents relevant information regarding the exposure to household (HAP) - and not traffic-related - air pollution and the sickness severity among Ugandan children. It is very impressive because Uganda is one of the many low- and middle-income countries that rely on biomass combustion for cooking, heating and lighting. This manuscript presents data from a noteworthy large sample size, 735 children from 20 hospitals, and convincing results and a very clear discussion. However, I still have some doubts on how they estimated the PM2.5 levels. Here are some minor points that should be addressed before accepting this manuscript for publication. Minor comments: # We need more details about the PM2.5 data. Was it measured in µg or estimated, like an index? Describe it better. -Lines 96-97: “We estimated the personal exposure of a young child to HAP using a log-linear model linking the kitchen concentration of PM2.5 to household variables [9].” Did you measure the PM2.5 concentration in the kitchens to estimate the real exposure? Mean measured PM2.5 should be presented in Table 2 too. -Lines 101-103: “The ratio between the daily average personal exposure and kitchen concentration (0.628 for young children) was applied to estimate exposures for children in our study [10].” What exactly does this ratio mean? Explain better. -“Statistically significant correlation between the PM2.5 and the SICK score (τ=0.15, p<0.0001). I cannot see this correlation in the graphic. What kind of variable was PM2.5 considered? # Lines 282-284: “This estimate has a moderate correlation (r = 0.56) with measured values of PM2.5 [9]. This may have reduced the precision of the exposure assessment.” The R value of the correlation was already stated before, in the methods. So, you do not need to repeat it. Reviewer #2: A. General Comments This is a well-researched, logical, and highly consistent manuscript that addresses a critical gap in global health literature. While there is extensive literature linking household air pollution (HAP) to the incidence of pneumonia, this study provides significant additional value by focusing specifically on the severity and prognosis of pneumonia among a high-risk, hospitalized, hypoxemic cohort. The large sample size (N=735) and the use of the validated "Signs of Inflammation in Children that Kill" (SICK) score provide a robust foundation for the authors' conclusions. The paper is written in excellent English and presents a compelling argument for HAP as a modifiable risk factor for pneumonia-related mortality. B. Specific Recommendations for Improvement 1. Clarity on Clinical Assessment Timing (Lines 108–115) The authors describe the calculation of the SICK score but do not explicitly state the timing of this assessment. While Table 1 suggests these were taken "at admission," the text should clarify if the SICK score represents a single baseline measurement upon hospital entry or a peak score during the stay. If it is an admission score, I recommend adding: "The SICK score was calculated upon initial hospital admission..." to line 111. 2. Magnitude of Association (Lines 182–187 & Figure 3A) The authors report a statistically significant correlation between PM2.5 and the SICK score using Kendall’s tau ( τ=0.15. While this confirms a relationship, it does not provide a clinically intuitive sense of the effect size. Recommendation: It would be highly valuable if the authors could provide a linear regression coefficient (β) to show the expected increase in SICK score points per unit (e.g., per 10 μg/m3) increase in PM2.5. This would allow clinicians to better understand the magnitude of risk. 3. Validity of the PM2.5 Modeling Approach (Lines 95–105) The authors utilize a log-linear model to estimate exposure. While direct monitoring (e.g., personal samplers) is often preferred, the authors correctly argue that their quantitative modeling is more practical and "pragmatic" for a large-scale study in a resource-limited setting. Recommendation: In the Discussion, the authors might briefly acknowledge that while the model has a moderate correlation (r=0.56) with measured values, it remains a superior alternative to simple dichotomous (Yes/No) fuel-type questionnaires, which are the standard in much of the existing literature. 4. Contextualizing Meta-Analysis Comparisons (Line 198) The text mentions that the odds of pneumonia are 1.8 times higher in households exposed to solid fuels. Recommendation: For clarity, please specify the comparison group used in this cited meta-analysis (e.g., compared to "clean-fuel households" or "non-exposed households"). 5. Definition of the Multidimensional Poverty Index (MPI) (Table 1) In Table 1, "MPI poor" is listed as a characteristic. The MPI is a complex composite index; the authors should briefly state the specific threshold or definition used to categorize a child as "MPI poor" in the footnote or Methods section to ensure reproducibility. 6. Formatting of Supplemental Material (Excel/CSV File) Upon reviewing the supplemental data file, the data appears to be formatted as a raw CSV where all parameters are contained in a single comma-separated column (Column A). Recommendation: To ensure the data is "Open Science" compliant and usable for other researchers, the authors should provide a properly formatted .xlsx or .csv file where each clinical and household variable is separated into its own clearly labeled column. C.Conclusion This study makes a strong contribution to the field by demonstrating that HAP is not just a risk factor for getting sick, but a driver of disease severity and mortality risk in children who are already hospitalized. The reasoning is sound, the limitations are honestly stated, and the clinical implications are clear. Following the minor clarifications above, the manuscript is well-suited for publication. Reviewer #3: While reviewing the materials of the study, several questions and minor comments arose: 1. The study states that the average daily concentration of PM 2.5 is 145 μg per cubic metre. This is a rather dangerous concentration, as it is 10 times higher than the WHO standard. This is an important value for research, as it determines the prediction of risks to children's health. Therefore, it was necessary to clarify how this value was measured or calculated and to provide the calculation method or source for such a method. 2. The study should have listed the cities or towns in Uganda where the research was conducted. This does not violate the personal data of respondents but will allow for future analysis of data from the air pollution monitoring system on the streets of the studied areas to confirm that the health hazard to children comes specifically from the use of domestic stoves indoors. 3. It is known that stove heating and cooking are still used in many rural homes without centralised gas supply, including in Eastern European countries. However, carbon monoxide, which is produced by the incomplete combustion of organic fuel, is traditionally considered the main threat to residents there. In this regard, it was also worth describing the typical models of stoves used in Ugandan households. ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #2: Yes: Thomas C. Carmine MD Reviewer #3: Yes: Buchavyi Yurii ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. -->
|
| Revision 1 |
|
Household air pollution is associated with disease severity in Ugandan children hospitalized with hypoxemic pneumonia PONE-D-25-36668R1 Dear Dr. Hawkes, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Srijan Lal Shrestha, Ph.D. Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-36668R1 PLOS One Dear Dr. Hawkes, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Srijan Lal Shrestha Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .